RP

Rajendra Pandurang Wanve

Active Director Director DIN 08396747
DIN 08396747 First appointment Oct 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2021
Shareholding value •••• Premium profile

About Rajendra Pandurang Wanve

Data last updated:

Rajendra Pandurang Wanve is a Director at Rhexia Healthcare Private Limited (since 2021). The company operates in Pharma. Rhexia Healthcare Private Limited reported revenue of ₹3.32 Cr (FY 2024).

DIN 08396747
Primary Designation Director
Industry Pharma
First Appointment 01 Oct 2021
Oldest Company Age 7 yrs
Largest company Rhexia Healthcare Private Limited · ₹3.32 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rhexia Healthcare Private Limited U51397PN2019PTC182934
Director01 Oct 20212019₹3.32 Cr (FY 2024)Active

Board colleagues of Rajendra Pandurang Wanve

Directorship timeline

Open interactive timeline →
Rhexia Healthcare Private Limited
Premium access

Shareholding and investment profile for Rajendra Pandurang Wanve

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajendra Pandurang Wanve

Rajendra Pandurang Wanve currently holds 1 directorship: Rhexia Healthcare Private Limited (Director, since 01 Oct 2021, revenue ₹3.32 Cr (FY 2024)).

Rajendra Pandurang Wanve was first appointed on 01 Oct 2021 as Director at Rhexia Healthcare Private Limited.

The current boards of Rajendra Pandurang Wanve's companies include Chaya Shashikant Parmaj (Rhexia Healthcare Private Limited), Harshda Vishal Kadam (Rhexia Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available